4//SEC Filing
Thompson Rahsaan 4
Accession 0001209191-23-013839
CIK 0001806952other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:15 PM ET
Size
5.4 KB
Accession
0001209191-23-013839
Insider Transaction Report
Form 4
Thompson Rahsaan
Chief Legal Officer
Transactions
- Award
Option (right to buy)
2023-02-24+245,000→ 245,000 totalExercise: $2.13Exp: 2033-02-23→ Common Stock (245,000 underlying)
Footnotes (1)
- [F1]12.5% of the option shares shall vest on August 9, 2023, with the remaining option shares to vest in equal monthly installments over the following forty-two months.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001788524
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 6:15 PM ET
- Size
- 5.4 KB